Clinical Trial Update: Study of Rivaroxaban for CeREbral Venous Thrombosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for rivaroxaban in cerebral venous thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Venous Thrombosis

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: University of British Columbia | Conditions: Cerebral Venous Thrombosis | Phase 2 | Status: COMPLETED